Abiopharma

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

Riverstone Holdings Limited - Announcement

Duolingo Invests in World-Class Motion Design with Acquisition of Animade

Okeanis Eco Tankers Corp. – Ex Dividend Date

SION ALERT: Investigation Launched into Sionna Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm

Northern Trust Expands Relationship with First Sentier Group to Support Singapore Unit Trust Offering

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

ORBS attributes changed: Attr: Fin_status N -> D;

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Farajallah Awny Samaan Botros 🔴 sold 14.0K shares of TAKEDA PHARMACEUTICAL CO LTD (TAK) at $17.10 Transaction Date: Aug 10, 2026 | Filing ID: 037515

Insulet Deadline: PODD Investors with Losses in Excess of $100K Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit

Ibrahim Ramy Riad Ahmed 🔴 sold 7.3K shares of TAKEDA PHARMACEUTICAL CO LTD (TAK) at $17.10 Transaction Date: Aug 10, 2026 | Filing ID: 037514

Pacheco Rhonda Janice 🔴 sold 16.9K shares of TAKEDA PHARMACEUTICAL CO LTD (TAK) at $17.10 Transaction Date: Aug 10, 2026 | Filing ID: 037513

Duprey Lauren Rusckowski 🔴 sold 47.6K shares of TAKEDA PHARMACEUTICAL CO LTD (TAK) at $17.10 Transaction Date: Aug 10, 2026 | Filing ID: 037509

Director Plump Andrew Stewart 🔴 sold 165.4K shares of TAKEDA PHARMACEUTICAL CO LTD (TAK) at $17.10 ($2.8M) Transaction Date: Aug 10, 2026 | Filing ID: 037507